Impact Factor
2.49
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.10
124 total citations
h5-index
17
h5 depth signal
Cited share
48.7%
55 of 113
Total citations
124
Citation footprint
Metric signal
0.97
External metric anchor
Self-citation
6.5%
8 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
191
Iran
68
United States
66
Thailand
64
India
61
Citing Fields of Research
Hematology
818
Genetics & Genomics
97
Metal Homeostasis
57
Congenital Disorders
30
Cytogenetics
28
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,511
Articles tracked across the journal lifetime
Indexed publication set
113
55 cited publications
Last 12 months
93
7.8 publications/month
Open access share
11.8%
11 OA publications in the last year
Leading citing country
China
191 citing publications
Leading citing field
Hematology
818 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v1n1, 1976/77-
v1n1, 1976/77-
Active Coverage
Research Focus & Classification
Indexed Subjects
Hematology
Broad Categories
Hematology
MeSH Descriptors
Hemoglobins
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1080/03630269.2026.2725724
Open DOI
Precision Medicine in Sickle Cell Disease: From Molecular Pathways to Curative Strategies
02
DOI 10.1080/03630269.2026.2729185
Open DOI
Endocrine Complications in Patients with Congenital Dyserythropoietic Anemia: A Single-Center Cohort Study
Congenital dyserythropoietic anemia (CDA) is a rare hereditary disorder marked by ineffective erythropoiesis and distinctive morphological abnormalities of erythroblasts. A hemolytic component is o...
03
DOI 10.1080/03630269.2026.2736312
Open DOI
Metabolomic and Proteomic Profiling of Vaso-Occlusive Crises in Sickle Cell Disease: Current Evidence and Future Perspectives
04
DOI 10.1080/03630269.2026.2732039
Open DOI
Evaluation of a Customized RDB-FTH Panel for β-Globin Variants in a Malaysian Tertiary Center
β-Thalassemia is the most prevalent autosomal recessive hereditary single gene disorder, resulting from reduced or absent β-globin chains synthesis, leading to ineffective erythropoiesis [1]. Clini...
05
DOI 10.1080/03630269.2026.2729189
Open DOI
CRISPR-Based Mediated Reactivation of Fetal Hemoglobin as a Therapeutic Strategy for Hemoglobinopathies: Evidence from Preclinical to Clinical Trials in Sickle Cell Disease and β-Thalassemia
Hemoglobin (Hb) is the protein found in erythrocytes that is necessary for transporting oxygen in the body. Its structure is a tetramer of four globin subunits, each linked to a heme prosthetic gro...
06
DOI 10.1080/03630269.2026.2730439
Open DOI
Genotype-Specific Hematologic Signatures Across α-Globin Defect Categories in α-Thalassemia
07
08
DOI 10.1080/03630269.2026.2723431
Open DOI
Uncovering the True Genotype: Unusually Severe Sickle Cell Disease in a Child with an Initial HbSC Diagnosis
09
DOI 10.1080/03630269.2026.2729184
Open DOI
Ocular Complications Among Patients with Beta-Thalassaemia Major and Intermedia: A Comparative Study from Pakistan
10
DOI 10.1080/03630269.2026.2723428
Open DOI
Co-Heredity of (−α)20.5 Deletion and IVS I-1 G > A ( HBB : C.92 + 1 G > A) Mutations in a Pediatric Patient: A Cause of Moderate Anemia Phenotype?
Approximately 70,000 newborns are born with thalassemia each year worldwide [1]. With an estimated 7% of the global population carrying a hemoglobinopathy gene, this inherited disorder represents a...
Bibliographical & Catalog Notes
Imprint varies.
Print issues ceased with v. 36 (2012).
Also issued online.
(1989)19890915 Notice not published Printed on acid-free paper